Power Calculations, Effect Sizes, and 30-Day Mortality in Enterobacteriaceae Bacteremia

Affiliations

¹ Department of Pharmacy, University of Utah Health, Salt Lake City, Utah.
² Division of Infectious Diseases, Washington University School of Medicine in St Louis, Missouri.

Comment

Tristan T Timbrook et al. JAMA Intern Med. 2019.

. 2019 Jun 1;179(6):849-850.

doi: 10.1001/jamainternmed.2019.1190.

¹ Department of Pharmacy, University of Utah Health, Salt Lake City, Utah.
² Division of Infectious Diseases, Washington University School of Medicine in St Louis, Missouri.

No abstract available

Comment on

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.
Tamma PD, Conley AT, Cosgrove SE, Harris AD, Lautenbach E, Amoah J, Avdic E, Tolomeo P, Wise J, Subudhi S, Han JH; Antibacterial Resistance Leadership Group. Tamma PD, et al. JAMA Intern Med. 2019 Mar 1;179(3):316-323. doi: 10.1001/jamainternmed.2018.6226. JAMA Intern Med. 2019. PMID: 30667477 Free PMC article.